For Chronic Myeloid Leukemia Patient Group Advocates
CML Advocates Network, November 2021
Global Leukemia Patient Experience Survey 2021
Are you suffering from Leukemia?
Take the Global Leukemia Patient Experience Survey 2021 we are running in partnership with Acute Leukemia Advocates Network (ALAN) and CLL Advocates Network (CLLAN) to create patient-based evidence on the key issues, experiences and unmet needs for leukemia patients and caregivers. It’s available now in 10 languages. Thanks for your collaboration!
Patient Advocacy Conferences
The months of October and November are known in the leukemia community for holding several important events run by the different patient advocacy networks.
Our colleagues of the CLL Advocates Network held the CLL Horizons Virtual Conference 2021 on 5-7 November. It was a unique opportunity for Chronic Lymphocytic Leukemia, patient advocates to learn about treatments and latest research, hear from fellow advocates on key topics, and meet and network with others discussing issues facing CLL patients.
Have a look at the program’s event: https://www.clladvocates.net/program/cll-horizons/
Our colleagues from MPN Advocates Network successfully held 6th MPN Horizons Conference on 12-14 November 2021. Delegates from MPN member organizations from all of the world attended this virtual meeting to exchange ideas, share best practices and provide a platform to start networking across borders. Have a look at the event’s information: https://www.mpn-advocates.net/mpn-horizons-2021/
We are pleased to congratulate our member in Argentina, ALMA Asociación Leucemia Mieloide Argentina, that will virtually held the 1st International Congress for Patients with Leukemia on 24-27th November 2021. The conference language was Spanish.
This was an excellent opportunity to take part of the leukemia patient community updating knowledge on all types of leukemias (CML, CLL and AL), patient advocacy and communication from key experts as Dr. Jorge Cortés, Dra. Beatriz Moiragui or Dra. Carolina Pavlovski, gathering over 5000 attendees from all regions and making this conference a remarkable online event for the leukemia community.Find out more about it: https://www.congresodepacientesonline.com
On 18th November, we were attending the European Cancer Summit 2021 and our co-founder Jan Geissler was also participating in a panel discussion about “From plans to action” – “The European Union Cancer Mission & Research” bringing the patient voice to this valuable European forum. In Jan’s words, “The EU Mission Cancer has many good plans in terms of addressing prevention, inequalities, cancer research and data interoperability, but I am worry about lack of meaningful patient involvement.”
ASH2021 is fast approaching so that we have prepared a selection of the most critical presentations on CML to be made at the 63rd ASH Annual Meeting and Exposition to take place in Atlanta, Georgia – and virtually – from December 11-14, 2021, like the following:
• Oral Abstracts presentations: “Progress with response prediction and TKI discontinuation” or “Mechanisms of resistance and expanded therapies”
• CML Education Program “Success Breeds More Success”
• Special Interest Session with the participation of our co-founder Jan Geissler “The Role of Real World Data Collection in Hematologic Malignancies”.